High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.8M
$2,824,768
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| VNDA |
Vanda Pharmaceuticals Inc.
|
CEO
Discretionary Sell
|
2026-03-02 | $1,276,971Large | S | Form 4 |
|
VNDA
S
Vanda Pharmaceuticals Inc.
Birznieks Gunther
• Officer • SVP, Business Development
Discretionary Sell
2026-03-02
$350,730
|
||||||
| VNDA |
Vanda Pharmaceuticals Inc.
|
Officer • SVP, Business Development
Discretionary Sell
|
2026-03-02 | $350,730 | S | Form 4 |
|
VNDA
S
Vanda Pharmaceuticals Inc.
Williams Timothy
• Officer • SVP & General Counsel
Discretionary SellΔOwn -10.1%
2026-03-02
$350,755
|
||||||
| VNDA |
Vanda Pharmaceuticals Inc.
|
Officer • SVP & General Counsel
Discretionary SellΔOwn -10.1%
|
2026-03-02 | $350,755 | S | Form 4 |
|
VNDA
S
Vanda Pharmaceuticals Inc.
Wijkstrom Joakim
• Officer • SVP, Chief Marketing Officer
Discretionary Sell
2026-03-02
$254,590
|
||||||
| VNDA |
Vanda Pharmaceuticals Inc.
|
Officer • SVP, Chief Marketing Officer
Discretionary Sell
|
2026-03-02 | $254,590 | S | Form 4 |
| VNDA |
Vanda Pharmaceuticals Inc.
|
CFO
Discretionary Sell
|
2026-03-02 | $350,821 | S | Form 4 |
|
VNDA
S
Vanda Pharmaceuticals Inc.
Honore Tage
• Director
Discretionary SellΔOwn -24.3%
2026-02-23
$240,900
|
||||||
| VNDA |
Vanda Pharmaceuticals Inc.
|
Director
Discretionary SellΔOwn -24.3%
|
2026-02-23 | $240,900 | S | Form 4 |